Pure Global

Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing - India CDSCO Medical Device Registration

Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing
UID: MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765

Brand Name

RPR

Device Class

Class D

Approving Authority

Sub Zonal Goa

Product Information

Eryscreen Plus is a reagent combipack for ABO grouping, Rho (RPR) typing and confirmation by slide or tube test and is 100% specific to A1, A2, Ax, B, negative reacting with Acquired B characteristics, A & B antigen and Rho(RPR) antigens

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing